Buscar (Noticias)

Arvinas Announces FDA Approval Of VEPPANU (Vepdegestrant) For The Treatment Of Esr1m, ER+/HER2- Advanced Breast Cancer

english top health

(MENAFN - GlobeNewsWire - Nasdaq) – VEPPANUTM is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader – – Approval received in advance of FDA-assigned PDUFA date of ...
2026-05-01 12:46:06